Santhera Pharmaceuticals Holdings Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of SPHDF for the last semiannual is 15.70 M USD, and it's 86.71% lower compared to the previous semiannual. The net income of H1 24 is -16.98 M USD.